News & Perspective

Dec 08, 2006

Dec 08, 2006

Donors pledge $475 million for global avian flu fight

(CIDRAP News) – International donors at a conference in Mali today pledged US $475 million to battle H5N1 avian influenza, according to the United Nations Food and Agriculture Organization (FAO).

Dr. David Nabarro, the UN's avian and pandemic influenza coordinator, said he was pleased with the amount, even though has been saying that $500 million to $750 million per year will be needed for the next 2 to 3 years.

Oct 24, 2006

Oct 24, 2006

Novartis claims success in trial of cell-based flu vaccine

(CIDRAP News) – Swiss pharmaceutical maker Novartis claimed success last week in a phase 3 clinical trial of a seasonal influenza vaccine produced in cell culture rather than in eggs, the conventional production method.

In a news release, the company said volunteers who received the vaccine had at least as strong an immune response as did volunteers immunized with an egg-based vaccine containing the same flu virus strains.

Sep 22, 2006

Sep 22, 2006

Mild H5 flu virus found in Montana ducks

(CIDRAP News) – Wild ducks in Montana were found to be carrying what may be an H5N1 avian influenza virus, but not the lethal Asian strain of H5N1, US officials announced yesterday.

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

Sep 07, 2006

Sep 07, 2006

Chinese report results for whole-virus H5N1 vaccine

Sept 7, 2006 (CIDRAP News) – In a human trial in China, a whole-virus H5N1 avian influenza vaccine generated an immune response with a relatively low dose of antigen, suggesting that it could be used to immunize more people than may be possible with some other vaccines under development.

Aug 31, 2006

Aug 31, 2006

Thai researcher says dog had H5N1 avian flu

(CIDRAP News) – A dog in Thailand's central Suphan Buri province contracted avian influenza after eating infected ducks, according to a Thai researcher quoted in a newspaper.

Jul 20, 2006

Jul 20, 2006

WHO confirms Indonesia's 54th avian flu case

(CIDRAP News) – A World Health Organization (WHO) reference laboratory confirmed today that a 44-year-old man who died on Jul 12 near Jakarta had H5N1 avian influenza.

The WHO announcement brings Indonesia’s official avian flu toll to 54 cases with 42 deaths. The country is now tied with Vietnam for the most deaths.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Jul 07, 2006

Jul 07, 2006

Spain reports first avian flu case in birds

(CIDRAP News) – Spain today became the latest country to join the list of nations responding to outbreaks of H5N1 avian influenza, as officials reported finding the virus in a wild bird.

Jun 28, 2006

Jun 28, 2006

Report: Flu pandemic could cut economic output 3-9%

(CIDRAP News) – An influenza pandemic would reduce the gross domestic products of the world's major economies by amounts ranging from 9% in China to 3% in Canada, according to a recent report by the Australian Bureau of Agricultural and Resource Economics (ABARE).

Pages

Sort Results

 

Narrow results

by country

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»